NCT01144962 - Dose-escalating Therapeutic Study of Allogeneic Bone Marrow Derived Mesenchymal Stem Cells for the Treatment of Fistulas in Patients With Refractory Perianal Crohn's Disease | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

June 30, 2010

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions

Crohn's DiseaseFistula

Interventions

PROCEDURE

Localization, curettage of the fistulous tract and closure of the internal opening without MSC injection.

Patients will undergo surgical localization, curettage of the fistulous tract and closure of the internal opening, without injection of MSCs.

PROCEDURE

Localization, curettage of the fistulous tract and closure of the internal opening with local MSC injection.

Patients will undergo surgical localization, curettage of the fistulous tract and closure of the internal opening, with local injection of indicated dose of MSCs

Trial Locations (1)

2333 ZA

Leiden University Medical Center (LUMC), Leiden